Exosomal miR-196a-1 promotes gastric cancer cell invasion and metastasis by targeting SFRP1
Abstract
Aim: To investigate the role of exosomal miRNAs on gastric cancer (GC) metastasis. Materials & methods: miRNA expression profiles of exosomes with distinct invasion potentials were analyzed using miRNA microarray and validated by quantitative real-time PCR. In vitro and in vivo experiments assessed the role of exosomal miR-196a-1 in GC's metastasis. Results: High expression level of exosomal miR-196a-1 expression was significantly associated with poor survival in GC. Exosomes that contained miR-196a-1 were secreted from high-invasive GC cells. Ectopic miR-196a-1 expression promoted invasion of low-invasive GC cells by targeting SFRP1. Conclusion: miR-196a-1 was delivered from high-invasive GC into low-invasive GC cells via exosomes and promoted metastasis to the liver in vitro and in vivo.
Papers of special note have been highlighted as: • of interest •• of considerable interest
References
- 1. . Global cancer statistics, 2012. CA Cancer J. Clin. 65(2), 87–108 (2015). • Introduces global cancer incidence.
- 2. . Gastric cancer. Lancet 388, 2654–2664 (2016).
- 3. . MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2), 281–297 (2004).
- 4. MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor. PLoS Genet. 6(3), e1000879 (2010).
- 5. MicroRNA-647 targets SRF-MYH9 axis to suppress invasion and metastasis of gastric cancer. Theranostics 7(13), 3338–3353 (2017).
- 6. miR-1207-5p and miR-1266 suppress gastric cancer growth and invasion by targeting telomerase reverse transcriptase. Cell Death Dis. 5(1), e1034 (2014).
- 7. . MicroRNA‐106a targets TIMP2 to regulate invasion and metastasis of gastric cancer. FEBS Lett. 588(4), 600 (2014).
- 8. . Exosomes: composition, biogenesis, and function. Nat. Rev. Immunol. 2(8), 569–579 (2002).
- 9. . Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9(6), 654–659 (2007). •• Demonstrates exosomal miRNAs are a genetic exchange between cells.
- 10. Glioblastoma microvesicles transport RNA and proteins that promote tumor growth and provide diagnostic biomarkers. Nat. Cell Biol. 10(12), 1470 (2008).
- 11. Tumor exosome integrins determine organotropic metastasis. Nature 527(7578), 329 (2015).
- 12. Exosome-delivered EGFR regulates liver microenvironment to promote gastric cancer liver metastasis. Nat. Commun. 8, 15016 (2017). • Demonstrates exosome regulates liver microenvironment to favor gastric cancer liver metastasis.
- 13. . Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma. Sci. Rep. 6, 38750 (2016).
- 14. . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-δ δ C(T)) method. Methods 25(4), 402–408 (2012).
- 15. . Gastic cancer. Lancet 362(9380), 305–315 (2003).
- 16. A positive crosstalk between CXCR4 and CXCR2 promotes gastric cancer metastasis. Oncogene 36(36), 5122–5133 (2017).
- 17. MVP-mediated exosomal sorting of miR-193a promotes colon cancer progression. Nat. Commun. 8, 14448 (2017).
- 18. . Oncogenic KIT-containing exosomes increase gastrointestinal stromal tumor cell invasion. Proc. Natl Acad. Sci. USA 111(2), 711 (2014).
- 19. Exosomes from glioma-associated mesenchymal stem cells increase the tumorigenicity of glioma stem-like cells via transfer of miR-1587. Cancer Res. 77(21), 5808–5819 (2017).
- 20. Exosome-carried microRNA-375 inhibits cell progression and dissemination via Bcl-2 blocking in colon cancer. J. Gastrointestin. Liver Dis. 24(4), 435–443 (2015).
- 21. Tumor-derived exosomes promote tumor progression and T-cell dysfunction through the regulation of enriched exosomal microRNAs in human nasopharyngeal carcinoma. Oncotarget 5(14), 5439 (2014).
- 22. . The Jeanne Manery-Fisher Memorial Lecture 1991. Maturation of reticulocytes: formation of exosomes as a mechanism for shedding membrane proteins. Biochem. Cell Biol. 70(3–4), 179–190 (1992).
- 23. B lymphocytes secrete antigen-presenting vesicles. J. Exp. Med. 183(3), 1161–1172 (1996).
- 24. Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes. Blood 119(3), 756–766 (2012). • Demonstrates miRNAs can be transferred between cells via exosomes.
- 25. . Exosomes: extracellular organelles important in intercellular communication. J. Proteomics 73(10), 1907–1920 (2010).
- 26. . Visualizing of the cellular uptake and intracellular trafficking of exosomes by live‐cell microscopy. J. Cell Biochem. 111(2), 488 (2010).
- 27. Exosome-mediated transfer of microRNAs within the tumor microenvironment and neuroblastoma resistance to chemotherapy. J. Natl Cancer Inst. 107(7), djv135 (2015).
- 28. Loss of exosomal miR-320a from cancer-associated fibroblasts contributes to HCC proliferation and metastasis. Cancer Lett. 397, 33–42 (2017). •• Demonstrates exosomal miRNAs in cancer associated fibroblasts are important for cancer progression.
- 29. Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells. Mol. Cancer 10(1), 117 (2011).
- 30. . Five miRNAs considered as molecular targets for predicting neuroglioma. Tumor Biol. 37(1), 1–9 (2016).
- 31. . MicroRNA miR-181a correlates with morphological sub-class of acute myeloid leukemia and the expression of its target genes in global genome-wide analysis. Leukemia 21(5), 912 (2007).
- 32. . Methylation-associated silencing of SFRP1 with an 8p11–12 amplification inhibits canonical and non-canonical WNT pathways in breast cancers. Int. J. Cancer 125(7), 1613–1621 (2009).
- 33. . MicroRNA-27a promotes the proliferation and invasiveness of colon cancer cells by targeting SFRP1 through the Wnt/β-catenin signaling pathway. Cell Physiol. Biochem. 42(5), 1920–1933 (2017). • Demonstrates SFRP1/Wnt signal in cancer progression.
- 34. The Wnt antagonist secreted frizzled‐related protein‐1 controls osteoblast and osteocyte apoptosis. J. Cell. Biochem. 96(6), 1212–1230 (2005).
- 35. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat. Genet. 36(4), 417–422 (2004).
- 36. . Frequent promoter hypermethylation of Wnt pathway inhibitor genes in malignant astrocytic gliomas. Int. J. Cancer 126(11), 2584–2593 (2010).
- 37. Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer. Br. J. Cancer 98(6), 1147 (2008).